Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Puerto Rico for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Puerto Rico only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Puerto Rico (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Alivia Specialty, LLC (NPI 1306182548)

Field	Value
Entity Type	Organization
Organization	Alivia Specialty, LLC
Address	Amelia Industrial Park, Calle Diana Lote 18
City	Guaynabo
State	PR
ZIP	00968
Taxonomy	Specialty Pharmacy
NPI Enumerated	December 17, 2012
NPI Deactivated	May 13, 2015

Payer Source	Total Paid
Medicaid	$189M
Medicare	$0

Key Findings

ALIVIA SPECIALTY, LLC is effectively a Medicaid-focused specialty pharmacy: it reports $189M in lifetime Medicaid revenue and has no Medicare billing on file. The entity’s NPI was enumerated 2012-12-17 (~14 years ago), indicating more than a decade of operation in the state Medicaid market.

Revenue is highly concentrated in a small set of oncology and high-cost biologic agents: the precomputed top 3 Medicaid codes account for 50.1% of this provider’s total Medicaid revenue, with J9271 generating $58.9M (31.9%), J9035 generating $19M (10.3%), and J9299 generating $14.6M (7.9%). This concentration means a few agents drive a majority of dollars.

The code mix (J9271, J9035, J9299, J9306, J9355 and others) is characteristic of a specialty oncology/immunotherapy dispensing operation that handles expensive infused and injectable biologics. Presence of agents across oncology, immune therapies, and high-cost supportive drugs suggests operations that include complex inventory management and payer authorization workflows typical of specialty pharmacies.

ALIVIA appears dominant in pembrolizumab within the state: J9271 has 5.5K claims, a $10639 avg paid/claim, and $58.9M revenue, and the provider ranks #1 of 6 in-state at the 100th percentile with a label of notably above typical state volume. This combination of high volume and high average payment positions the provider as a major state supplier for this specific agent.

The provider also posts strong in-state positions on additional high-revenue biologics: J9035 (bevacizumab) has 4.1K claims, $4601 avg paid/claim, $19M revenue and ranks #2 of 23 (95th percentile, notably above typical), while J9306 (pertuzumab) has $14.1M revenue and ranks #1 of 5 (100th percentile, typical, unremarkable volume). These rankings show the provider is a leading regional supplier for several high-cost oncology agents rather than a marginal participant.

ALIVIA is the sole in-state reporter for many high-cost or niche agents: multiple codes (for example Q5107, J9042, J9145, Q5117, J9354, J2353, J9144, J9317, J3380, J9047, J0490) are listed as #1 of 1 with a note of no state peer volume comparison available. Being the only in-state reporter for several of these agents suggests the provider supplies drugs that few other local organizations dispense or that it serves niche clinical channels.

Per-claim payment levels emphasize the high-cost nature of the portfolio and operational capital demands: examples include J9042 at a $37711 avg paid/claim, J9358 at $10193 avg paid/claim, J9022 at $9914 avg paid/claim, and J9299 at $9000 avg paid/claim. These outsized average payments underscore the provider’s exposure to single-claim financial swings and the importance of specialty pharmacy cash-flow and inventory practices.

Concentration and single-payer exposure create monitoring priorities: with top 3 codes making up 50.1% of Medicaid revenue and effectively no Medicare claims on file, ALIVIA’s revenue is vulnerable to utilization shifts, formulary decisions, or payer contract changes affecting a handful of agents. Analysts should watch utilization trends for J9271, J9035, and J9299 and any state Medicaid policy changes for high-cost biologics that could materially affect the provider’s revenue base.

Medicaid: Complete Services Breakdown

Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.

60 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	5,530	$10,640	$58.9M
J9035	Injection, bevacizumab, 10 mg	4,120	$4,600	$19M
J9299	Injection, nivolumab, 1 mg	1,620	$9,000	$14.6M
J9306	Injection, pertuzumab, 1 mg	2,370	$5,940	$14.1M
J9355	Injection, trastuzumab, excludes biosimilar, 10 mg	2,000	$4,690	$9.4M
J0897	Injection, denosumab, 1 mg	3,100	$2,680	$8.3M
J9358	Injection, fam-trastuzumab deruxtecan-nxki, 1 mg	720	$10,190	$7.3M
J9312	Injection, rituximab, 10 mg	1,160	$5,370	$6.2M
J2777	Injection, faricimab‑svoa, 0.1 mg	2,380	$2,390	$5.7M
J9022	Injection, atezolizumab, 10 mg	540	$9,910	$5.4M

Showing 1–10 of 60

Medicaid: Competitive Analysis & Benchmarks

How this provider's Medicaid billing volume and revenue compare to other Puerto Rico providers billing the same CPT/HCPCS codes.

Claims Volume vs. Puerto Rico Distribution

Alivia Specialty, LLC — 10 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Puerto Rico

Full comparison — all codes billed, vs. Puerto Rico median

60 rows

CPT/HCPCS Code	Description	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	Injection, pembrolizumab, 1 mg	1	10	220	$9,780	$16.9M
J9299	Injection, nivolumab, 1 mg	2	10	1,120	$7,470	$8M
J2777	Injection, faricimab‑svoa, 0.1 mg	1	10	2,380	$2,390	$5.7M
J9306	Injection, pertuzumab, 1 mg	1	10	420	$5,490	$5M
Q5107	Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg	1	10	1,570	$2,950	$4.6M
J9355	Injection, trastuzumab, excludes biosimilar, 10 mg	2	10	490	$4,520	$4.4M
J9042	Injection, brentuximab vedotin, 1 mg	1	10	110	$37,710	$4M
J9145	Injection, daratumumab, 10 mg	1	10	530	$7,300	$3.9M
J9358	Injection, fam-trastuzumab deruxtecan-nxki, 1 mg	1	10	380	$10,180	$3.8M
Q5117	Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg	1	10	1,480	$2,430	$3.6M

Showing 1–10 of 60

Nearby Providers

Other providers in the same ZIP code as Alivia Specialty, LLC, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Medtronic Puerto Rico Operations	PR	Durable Medical Equipment & Medical Supplies	$0	$19.7M
Cuerpo De Emergencias Medicas De	PR	Land Ambulance	$108.2K	$9.4M
Ortho & Surgical Solutions, Inc	PR	Prosthetic/Orthotic Supplier	$0	$7.8M
Santa Merle	PR	Hematology & Oncology Physician	$4.5K	$2M
Bard Shannon Limited	PR	Prosthetic/Orthotic Supplier	$0	$1.2M
Guaynabo Ambulatory Surgical Group, Inc	PR	Ambulatory Surgical Clinic/Center	$275K	$53.4K
Ricardo Hernandez-castillo	PR	Pulmonary Disease Physician	$28.6K	$211.9K
Maria De Aranzazu Villamil Jarauta	PR	Endocrinology, Diabetes & Metabolism Physician	$42.3K	$151.8K
Juan Malpica-santiago	PR	Pulmonary Disease Physician	$33.2K	$148.3K
Fernando Zalduondo	PR	Diagnostic Radiology Physician	$125.9K	$0

Alivia Specialty, LLC — Billing Profile & Reimbursement Data

Sign up for Alivia Specialty, LLC — Billing Profile & Reimbursement Data policy alerts

Alivia Specialty, LLC — Billing Profile & Reimbursement Data

Sign up for Alivia Specialty, LLC — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicaid: Total Revenue Breakdown by CPT/HCPCS Code

Medicaid: Complete Services Breakdown

Medicaid: Competitive Analysis & Benchmarks

Nearby Providers

Frequently Asked Questions

References